nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A8—Liothyronine—hypothyroidism	0.285	0.506	CbGbCtD
Minocycline—SLC22A8—Liotrix—hypothyroidism	0.278	0.494	CbGbCtD
Minocycline—CASP3—cochlea—hypothyroidism	0.0242	0.11	CbGeAlD
Minocycline—CASP1—NOD pathway—DUOX2—hypothyroidism	0.0218	0.1	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0176	0.0809	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.0149	0.0688	CbGpPWpGaD
Minocycline—IL1B—NOD pathway—DUOX2—hypothyroidism	0.0136	0.0628	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0121	0.0558	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.0103	0.0475	CbGpPWpGaD
Minocycline—CASP3—nerve—hypothyroidism	0.00972	0.0443	CbGeAlD
Minocycline—CASP3—tongue—hypothyroidism	0.0095	0.0433	CbGeAlD
Minocycline—IL1B—Monoamine Transport—SLC5A7—hypothyroidism	0.00661	0.0305	CbGpPWpGaD
Minocycline—IL1B—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.00638	0.0294	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.00594	0.0274	CbGpPWpGaD
Minocycline—SLC22A8—urine—hypothyroidism	0.00502	0.0228	CbGeAlD
Minocycline—CASP3—FAS (CD95) signaling pathway—CLTC—hypothyroidism	0.00472	0.0217	CbGpPWpGaD
Minocycline—CASP1—heart—hypothyroidism	0.00438	0.0199	CbGeAlD
Minocycline—CYCS—Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.—ATP5O—hypothyroidism	0.00426	0.0196	CbGpPWpGaD
Minocycline—CYCS—heart—hypothyroidism	0.00421	0.0192	CbGeAlD
Minocycline—CASP1—cardiovascular system—hypothyroidism	0.00413	0.0188	CbGeAlD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.0041	0.0189	CbGpPWpGaD
Minocycline—CYCS—cardiovascular system—hypothyroidism	0.00398	0.0181	CbGeAlD
Minocycline—CASP1—gonad—hypothyroidism	0.00375	0.0171	CbGeAlD
Minocycline—CASP3—adrenal cortex—hypothyroidism	0.00373	0.017	CbGeAlD
Minocycline—VEGFA—Differentiation Pathway—TPO—hypothyroidism	0.00367	0.0169	CbGpPWpGaD
Minocycline—CASP1—pituitary gland—hypothyroidism	0.00366	0.0167	CbGeAlD
Minocycline—CASP3—heart—hypothyroidism	0.00361	0.0164	CbGeAlD
Minocycline—CYCS—gonad—hypothyroidism	0.00361	0.0164	CbGeAlD
Minocycline—MMP9—Endochondral Ossification—THRA—hypothyroidism	0.00357	0.0165	CbGpPWpGaD
Minocycline—CASP3—cardiovascular system—hypothyroidism	0.00341	0.0155	CbGeAlD
Minocycline—CYCS—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00328	0.0151	CbGpPWpGaD
Minocycline—CASP1—adrenal gland—hypothyroidism	0.00327	0.0149	CbGeAlD
Minocycline—CASP1—blood—hypothyroidism	0.00327	0.0149	CbGeAlD
Minocycline—CASP1—thyroid gland—hypothyroidism	0.00315	0.0144	CbGeAlD
Minocycline—CYCS—adrenal gland—hypothyroidism	0.00314	0.0143	CbGeAlD
Minocycline—CYCS—blood—hypothyroidism	0.00314	0.0143	CbGeAlD
Minocycline—VEGFA—Endochondral Ossification—THRA—hypothyroidism	0.0031	0.0143	CbGpPWpGaD
Minocycline—CASP3—gonad—hypothyroidism	0.00309	0.0141	CbGeAlD
Minocycline—CASP1—female gonad—hypothyroidism	0.00305	0.0139	CbGeAlD
Minocycline—CYCS—thyroid gland—hypothyroidism	0.00303	0.0138	CbGeAlD
Minocycline—CASP3—pituitary gland—hypothyroidism	0.00302	0.0137	CbGeAlD
Minocycline—VEGFA—Heart Development—NKX2-5—hypothyroidism	0.00298	0.0137	CbGpPWpGaD
Minocycline—CYCS—female gonad—hypothyroidism	0.00293	0.0134	CbGeAlD
Minocycline—VEGFA—adrenal cortex—hypothyroidism	0.00293	0.0134	CbGeAlD
Minocycline—IL1B—heart—hypothyroidism	0.00288	0.0131	CbGeAlD
Minocycline—VEGFA—heart—hypothyroidism	0.00284	0.0129	CbGeAlD
Minocycline—IL1B—cardiovascular system—hypothyroidism	0.00272	0.0124	CbGeAlD
Minocycline—CASP1—testis—hypothyroidism	0.0027	0.0123	CbGeAlD
Minocycline—CASP3—adrenal gland—hypothyroidism	0.00269	0.0123	CbGeAlD
Minocycline—CASP3—blood—hypothyroidism	0.00269	0.0123	CbGeAlD
Minocycline—CYCS—testis—hypothyroidism	0.0026	0.0118	CbGeAlD
Minocycline—CASP3—thyroid gland—hypothyroidism	0.0026	0.0118	CbGeAlD
Minocycline—CASP1—liver—hypothyroidism	0.00255	0.0116	CbGeAlD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—CLTC—hypothyroidism	0.00254	0.0117	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00252	0.0116	CbGpPWpGaD
Minocycline—CASP3—female gonad—hypothyroidism	0.00251	0.0114	CbGeAlD
Minocycline—CASP1—cerebellum—hypothyroidism	0.0025	0.0114	CbGeAlD
Minocycline—CYCS—liver—hypothyroidism	0.00246	0.0112	CbGeAlD
Minocycline—IL1B—pituitary gland—hypothyroidism	0.00241	0.011	CbGeAlD
Minocycline—MMP9—heart—hypothyroidism	0.0024	0.0109	CbGeAlD
Minocycline—CYCS—cerebellum—hypothyroidism	0.0024	0.0109	CbGeAlD
Minocycline—VEGFA—pituitary gland—hypothyroidism	0.00237	0.0108	CbGeAlD
Minocycline—IL1B—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00228	0.0105	CbGpPWpGaD
Minocycline—MMP9—cardiovascular system—hypothyroidism	0.00227	0.0103	CbGeAlD
Minocycline—CASP3—testis—hypothyroidism	0.00223	0.0101	CbGeAlD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—hypothyroidism	0.00216	0.00996	CbGpPWpGaD
Minocycline—IL1B—adrenal gland—hypothyroidism	0.00215	0.0098	CbGeAlD
Minocycline—IL1B—blood—hypothyroidism	0.00215	0.0098	CbGeAlD
Minocycline—VEGFA—adrenal gland—hypothyroidism	0.00212	0.00964	CbGeAlD
Minocycline—CASP3—liver—hypothyroidism	0.00211	0.00959	CbGeAlD
Minocycline—IL1B—thyroid gland—hypothyroidism	0.00208	0.00946	CbGeAlD
Minocycline—CASP3—cerebellum—hypothyroidism	0.00206	0.00937	CbGeAlD
Minocycline—VEGFA—thyroid gland—hypothyroidism	0.00204	0.0093	CbGeAlD
Minocycline—IL1B—female gonad—hypothyroidism	0.00201	0.00914	CbGeAlD
Minocycline—VEGFA—female gonad—hypothyroidism	0.00197	0.00899	CbGeAlD
Minocycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00193	0.00891	CbGpPWpGaD
Minocycline—ALOX5—heart—hypothyroidism	0.0019	0.00865	CbGeAlD
Minocycline—MMP9—adrenal gland—hypothyroidism	0.00179	0.00817	CbGeAlD
Minocycline—MMP9—blood—hypothyroidism	0.00179	0.00817	CbGeAlD
Minocycline—ALOX5—cardiovascular system—hypothyroidism	0.00179	0.00816	CbGeAlD
Minocycline—IL1B—testis—hypothyroidism	0.00178	0.00811	CbGeAlD
Minocycline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00176	0.00808	CbGpPWpGaD
Minocycline—VEGFA—testis—hypothyroidism	0.00175	0.00797	CbGeAlD
Minocycline—MMP9—Osteopontin-mediated events—VAV3—hypothyroidism	0.0017	0.00783	CbGpPWpGaD
Minocycline—IL1B—liver—hypothyroidism	0.00168	0.00766	CbGeAlD
Minocycline—MMP9—female gonad—hypothyroidism	0.00167	0.00762	CbGeAlD
Minocycline—VEGFA—liver—hypothyroidism	0.00165	0.00754	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00163	0.00749	CbGpPWpGaD
Minocycline—VEGFA—cerebellum—hypothyroidism	0.00162	0.00736	CbGeAlD
Minocycline—MMP9—FGF signaling pathway—BGLAP—hypothyroidism	0.0016	0.00736	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00152	0.00701	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00149	0.00684	CbGpPWpGaD
Minocycline—MMP9—testis—hypothyroidism	0.00148	0.00676	CbGeAlD
Minocycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00148	0.00679	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00147	0.00678	CbGpPWpGaD
Minocycline—CASP3—Cell death signalling via NRAGE, NRIF and NADE—VAV3—hypothyroidism	0.00142	0.00656	CbGpPWpGaD
Minocycline—ALOX5—adrenal gland—hypothyroidism	0.00142	0.00646	CbGeAlD
Minocycline—ALOX5—blood—hypothyroidism	0.00142	0.00646	CbGeAlD
Minocycline—MMP9—liver—hypothyroidism	0.0014	0.00639	CbGeAlD
Minocycline—IL1B—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00138	0.00634	CbGpPWpGaD
Minocycline—SLC22A7—testis—hypothyroidism	0.00137	0.00625	CbGeAlD
Minocycline—ALOX5—thyroid gland—hypothyroidism	0.00137	0.00623	CbGeAlD
Minocycline—SLC22A11—liver—hypothyroidism	0.00133	0.00605	CbGeAlD
Minocycline—ALOX5—female gonad—hypothyroidism	0.00132	0.00602	CbGeAlD
Minocycline—CYCS—Ceramide signaling pathway—IGF1—hypothyroidism	0.00132	0.00607	CbGpPWpGaD
Minocycline—SLC22A7—liver—hypothyroidism	0.0013	0.00591	CbGeAlD
Minocycline—VEGFA—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00129	0.00594	CbGpPWpGaD
Minocycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00123	0.00567	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.00122	0.00561	CbGpPWpGaD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—VAV3—hypothyroidism	0.0012	0.00552	CbGpPWpGaD
Minocycline—ALOX5—testis—hypothyroidism	0.00117	0.00534	CbGeAlD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—VAV3—hypothyroidism	0.00112	0.00518	CbGpPWpGaD
Minocycline—ALOX5—liver—hypothyroidism	0.00111	0.00505	CbGeAlD
Minocycline—ALOX5—cerebellum—hypothyroidism	0.00108	0.00493	CbGeAlD
Minocycline—CASP1—Apoptosis—IGF1—hypothyroidism	0.000984	0.00453	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00098	0.00451	CbGpPWpGaD
Minocycline—SLC22A8—blood—hypothyroidism	0.000959	0.00437	CbGeAlD
Minocycline—IL1B—TCR Signaling Pathway—VAV3—hypothyroidism	0.000945	0.00435	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000879	0.00405	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000861	0.00397	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—IGF1—hypothyroidism	0.000842	0.00388	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000837	0.00385	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—VAV3—hypothyroidism	0.000837	0.00385	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000798	0.00367	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000737	0.00339	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000728	0.00335	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—VAV3—hypothyroidism	0.000717	0.0033	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000714	0.00329	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—VAV3—hypothyroidism	0.0007	0.00322	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—IGF1—hypothyroidism	0.000679	0.00313	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00067	0.00309	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000661	0.00304	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000659	0.00303	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000657	0.00302	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000648	0.00298	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IGF1—hypothyroidism	0.000641	0.00295	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—VAV3—hypothyroidism	0.000607	0.0028	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000586	0.0027	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—IGF1—hypothyroidism	0.000586	0.0027	CbGpPWpGaD
Minocycline—CYCS—Metabolism—IYD—hypothyroidism	0.000582	0.00268	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00056	0.00258	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000556	0.00256	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CLTC—hypothyroidism	0.000552	0.00254	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IGF1—hypothyroidism	0.000551	0.00254	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.000548	0.00252	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—VAV3—hypothyroidism	0.000517	0.00238	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—IGF1—hypothyroidism	0.000515	0.00237	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.000514	0.00237	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—IGF1—hypothyroidism	0.000509	0.00234	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ATP5O—hypothyroidism	0.000495	0.00228	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CLTC—hypothyroidism	0.000479	0.00221	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TPO—hypothyroidism	0.000465	0.00214	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000464	0.00214	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000447	0.00206	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—IGF1—hypothyroidism	0.000426	0.00196	CbGpPWpGaD
Minocycline—CASP1—Immune System—CLTC—hypothyroidism	0.000423	0.00195	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—VAV3—hypothyroidism	0.000414	0.00191	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000412	0.0019	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000405	0.00187	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000405	0.00187	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CLTC—hypothyroidism	0.000394	0.00181	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00039	0.0018	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00037	0.0017	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—IYD—hypothyroidism	0.000359	0.00165	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000352	0.00162	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000351	0.00162	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000344	0.00159	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—VAV3—hypothyroidism	0.000342	0.00157	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CLTC—hypothyroidism	0.000342	0.00157	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000341	0.00157	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000336	0.00155	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000319	0.00147	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000307	0.00141	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ATP5O—hypothyroidism	0.000305	0.0014	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPO—hypothyroidism	0.000287	0.00132	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000284	0.00131	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000282	0.0013	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000277	0.00127	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000271	0.00125	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000268	0.00123	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000266	0.00122	CbGpPWpGaD
Minocycline—IL1B—Immune System—CLTC—hypothyroidism	0.000264	0.00122	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VAV3—hypothyroidism	0.00026	0.0012	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000251	0.00116	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000236	0.00108	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SH2B3—hypothyroidism	0.00023	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—VAV3—hypothyroidism	0.000226	0.00104	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000224	0.00103	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TSHB—hypothyroidism	0.000215	0.000992	CbGpPWpGaD
Minocycline—CASP1—Immune System—PRL—hypothyroidism	0.000215	0.000991	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—IGF1—hypothyroidism	0.000213	0.000981	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000212	0.000977	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000211	0.000972	CbGpPWpGaD
Minocycline—CASP1—Immune System—VAV3—hypothyroidism	0.000199	0.000917	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3C2A—hypothyroidism	0.000192	0.000884	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000189	0.000869	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CLTC—hypothyroidism	0.000189	0.000869	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VAV3—hypothyroidism	0.000186	0.000855	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000179	0.000822	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000176	0.000811	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TRH—hypothyroidism	0.000163	0.000751	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000162	0.000746	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC5A5—hypothyroidism	0.000161	0.000743	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—VAV3—hypothyroidism	0.000161	0.000742	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—VAV3—hypothyroidism	0.000158	0.000728	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHB—hypothyroidism	0.000145	0.000669	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHR—hypothyroidism	0.000145	0.000669	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000141	0.000647	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000136	0.000627	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRL—hypothyroidism	0.000135	0.00062	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TSHB—hypothyroidism	0.000133	0.000611	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CLTC—hypothyroidism	0.000131	0.000603	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SH2B3—hypothyroidism	0.00013	0.000597	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000128	0.000587	CbGpPWpGaD
Minocycline—IL1B—Immune System—VAV3—hypothyroidism	0.000124	0.000573	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3C2A—hypothyroidism	0.000118	0.000545	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000117	0.000538	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CLTC—hypothyroidism	0.000114	0.000524	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000114	0.000523	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRH—hypothyroidism	0.000113	0.000521	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000107	0.000494	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHB—hypothyroidism	0.000101	0.000465	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHR—hypothyroidism	0.000101	0.000465	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC5A5—hypothyroidism	9.94e-05	0.000458	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRH—hypothyroidism	9.83e-05	0.000452	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF1—hypothyroidism	9.73e-05	0.000448	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRL—hypothyroidism	9.61e-05	0.000443	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH2B3—hypothyroidism	8.99e-05	0.000414	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	8.95e-05	0.000412	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VAV3—hypothyroidism	8.89e-05	0.000409	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHR—hypothyroidism	8.76e-05	0.000403	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHB—hypothyroidism	8.76e-05	0.000403	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AVP—hypothyroidism	8.57e-05	0.000394	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—hypothyroidism	8.44e-05	0.000388	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—hypothyroidism	7.81e-05	0.000359	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—hypothyroidism	6.67e-05	0.000307	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VAV3—hypothyroidism	6.17e-05	0.000284	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AVP—hypothyroidism	5.95e-05	0.000274	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—hypothyroidism	5.79e-05	0.000267	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—hypothyroidism	5.69e-05	0.000262	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—hypothyroidism	5.47e-05	0.000252	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VAV3—hypothyroidism	5.36e-05	0.000247	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—hypothyroidism	5.2e-05	0.000239	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AVP—hypothyroidism	5.16e-05	0.000238	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—hypothyroidism	3.95e-05	0.000182	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—hypothyroidism	3.8e-05	0.000175	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—hypothyroidism	3.43e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—hypothyroidism	3.3e-05	0.000152	CbGpPWpGaD
